Rising number of road accidents globally is another key factor expected to increase adoption of neuromodulation and neurostimulation devices.

Market.US announces the publication of its most recently generated research report titled, “Global Nerve Repair and Regeneration Market by Type (Nerve Conduit, Nerve Wrap, Nerve Graft and Nerve Cap), by Indication (Direct Nerve Repair/Neurorrhaphy, Nerve Graft), and by Region – Global Forecast to 2028”, which offers a holistic view of the Global Nerve Repair and Regeneration Market through systematic segmentation that covers every aspect of the target market.

The Global Nerve Repair and Regeneration Market is projected to be US$ 5,686.2 Mn in 2021 to reach US$ 8,210.0 Mn by 2028 at a CAGR of 5.2%.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons, and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching, or cutting of a nerve.

NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy, and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve, and vagus nerve stimulation.

Global Nerve Repair and Regeneration Market Revenue (US$ Mn), 2021–2028

Growing geriatric population and subsequent increase in neurological disorders amongst them is estimated to further augment the market growth. Increasing government spending on healthcare infrastructure, particularly in emerging economies and commercialization of products will prove to be major factors for growth of the nerve repair and regeneration market in these countries.

Emerging technological developments such as improved sensors, increased device memory, and rechargeable batteries in these devices is expected to further augment the market growth. Other developments including external signals to improve closed loop synchronizations is expected to be the next generation technology capability. In addition, increased number of electrodes to improve both stimulation and recording capacities in devices will also provide an added advantage to end-users.

High cost of surgeries and neurostimulation and neuromodulation devices, which reflects directly on treatment cost of patients is expected to be the major factor restraining growth of global nerve repair and regeneration market.

Global Nerve Repair and Regeneration Market Attractiveness Analysis by Type, 2012–2018

The research report on the Global Nerve Repair and Regeneration Market includes profiles of some of the major companies such as Abbott Laboratories, AxoGen Inc., Boston Scientific Corporation, LivaNova PLC, Medtronic plc, Nuvectra Corporation, Polyganics Holding B.V., and Stryker Corporation among Others.

Segmentation for Global Nerve Repair and Regeneration Market Based on Type, Indication, and Region

Based on Type

• Nerve Conduit
• Nerve Wrap
• Nerve Graft and Nerve Cap

Based on Indication

• Direct Nerve Repair/Neurorrhaphy
• Nerve Graft

Based on Key Players:-

• Abbott Laboratories
• AxoGen Inc.
• Boston Scientific Corporation
• LivaNova PLC
• Medtronic plc
• Nuvectra Corporation
• Polyganics Holding B.V.
• Stryker Corporation
• Others

Based on Region/Country

• United States
• China
• Europe
• Japan
• Southeast Asia
• India
• Rest of the World

For the Nerve Repair and Regeneration Market research study, the following years have been considered to estimate the market size: